Randomized trial comparing cetuximab plus XELIRI versus cetuximab plus XELOX as first line treatment of patients with metastatic colorectal cancer (mCRC): A study of the german AIO CRC study group
2008
4033 Background: Cetuximab combined with 5-fluorouracil/folinic acid (5-FU/FA) plus irinotecan or oxaliplatin has shown activity in the treatment of mCRC. This randomized trial compared the first-l...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
12
Citations
NaN
KQI